JERUSALEM, July 17, 2024 (GLOBE NEWSWIRE) — Dror Ortho-Design, Inc. (“Dror” or the “Company”) (OTC PINK: DROR), an artificial intelligence-based orthodontic platform company that has developed a proprietary solution to fix people’s smiles by straightening teeth using pulsed air delivered by a single custom smart aligner, today announced the launch of the new brand ‘ZSMILE’. The rebranding of the company’s platform to ‘ZSMILE’ by ‘Aerodentis’ aligns with the pending commercial launch of the revolutionary teeth straightening solution intended for use while sleeping or discreetly at home.
Figure 1 – Second generation ZSMILE solution
Figure 2 – ZSMILE works while you sleep
The ZSMILE platform aims to revolutionize the way people fix their smiles by leveraging recent advances in technology that have made traditional aligner solutions no longer the most effective treatment option. ZSMILE has been developed to correct people’s smiles in a discreet and gentle way, using a single smart aligner to gently move teeth into their optimal position with pulsating air while the patient sleeps or at home. Using AI technology, the ZSMILE platform allows General Dentists as well as Orthodontists to monitor and change their smile correction treatment program remotely, reducing the need for unnecessary office visits.
Lee Haddad, CEO of Dror, commented: “We believe our new ZSMILE brand captures the essence of our mission to enable people to fix their smile while they sleep without having to wear plastic in their mouth all day. the power of artificial intelligence to improve the smile correction process, enhancing treatment accuracy and efficiency.”
Visit the Company’s website at zsmile.com to learn more about how ZSMILE strives to bring efficiency and convenience to the smile makeover process.
Separately, on June 14, 2024, Dror’s registration statement on Form S-1, originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 9, 2024, as amended (File No. 333-276981) (the “ Registration Statement”), was declared effective by the Capital Market Commission. On June 17, 2024, Dror filed a final prospectus (the “Prospectus”) with respect to the securities registered in this Registration Statement, including shares issued to private placement investors and former Dror shareholders. The Registration Statement and Prospectus are accessible through the SEC’s website at www.sec.gov.
This press release is not an offer to sell or a solicitation of an offer to buy, nor will there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or certification under the laws of securities of any such state or jurisdiction.
About Dror Ortho-Design, Inc.
Dror Ortho-Design, Inc. is an artificial intelligence-based orthodontic platform company that has developed a proprietary solution to correct people’s smiles by straightening teeth using pulsed air delivered by a single custom smart aligner. Dror plans to disrupt the aligner market by offering millions of people a revolutionary alternative to traditional aligners. The Company believes that people do not need to change their lifestyle to fix their smile, as they are required to do with existing alignment solutions. Instead, we believe our solution will be able to provide customers with a discreet and hassle-free way to improve their smile, even while they sleep. The Company’s ZSMILE solution is also intended to provide General Dentists as well as Orthodontists a way to effectively grow their practice by offering a unique and scalable service.
For more information, visit: www.zsmile.com
Forward-looking statements
Statements made in this press release may be forward-looking statements within the meaning of federal securities laws that are subject to certain risks and uncertainties and involve factors that could cause actual results to differ materially from those projected or suggested. Factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: (i) Dror’s ability to obtain financing; (ii) Dror’s ability to attract and/or retain manufacturing, research, development and commercialization partners; (iii) Dror’s and/or a partner’s ability to successfully complete product research and development, including preclinical and clinical studies, and commercialization; (iv) Dror’s and/or a partner’s ability to obtain required government approvals; and (v) Dror’s and/or a partner’s ability to develop and commercialize products before, and that can compete favorably with, those of competitors. Additional factors that could cause actual results to differ materially from those anticipated or suggested in any forward-looking statements are contained in Dror’s most recent periodic reports filed with the US Securities and Exchange Commission, including our Annual Report on Form 10‑K. Our Quarterly Reports on Form 10‑Q and certain Current Reports on Form 8‑K. Dror undertakes no obligation to update and supplement forward-looking statements as a result of subsequent events.
For Investor Questions:
Ben Shamsian
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
The photos accompanying this announcement are available at:
SOURCE: Dror Ortho-Design, Inc.
